Management reported sharply increased annual and quarterly revenues driven by expanded activities in the Janssen partnership. Rusfertide demonstrated ability to maintain hematocrit below clinical ...

NEW BRUNSWICK, NJ – Biotech executive Dinesh Patel is supporting a new graduate fellowship at Rutgers University, marking a full circle moment for the scientist turned industry leader who began his ...

Welcome to the second day of the Citi Biopharma Back to School Summit. I'm Geoff Meacham. I'm the senior biopharma analyst and my team is with me here as well. So we're thrilled to have Protagonist ...

Hello again, everyone. I'm Etzer Darout, senior biotech analyst at Barclays. It's my pleasure to welcome Protagonist Therapeutics to our fireside. With me today, I have Dinesh Patel, the Chief ...

Dinesh Patel, Protagonist Therapeutics CEO, joins 'Fast Money' to talk earnings, commercialization, and partnerships. Got a confidential news tip? We want to hear from you. Sign up for free ...

NEWARK, CA / ACCESS Newswire / May 28, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer ...